Zdrowie i gospodarka · 12/11/2014

FDA Requests Public Comment on Proposed Collection of Information on Direct-to-Consumer Prescription Drug Ads

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to the impact of ad exposure frequency on perception and mental processing of risk and benefit information in direct-to-consumer prescription drug ads, as required by the Paperwork Reduction Act of 1995.